ONCOGENE-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=1055113, encodeId=75d71055113f0, content=感觉虽然有近10分，但投了一篇感觉蛮简单的，做蛋白对肿瘤作用的小伙伴可以大胆尝试一下。 审了两轮，也可能是运气比较好，审稿人问的问题都不难。 估计期刊整体对国人也比较友好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=23305505580, createdName=ms3000001738384174, createdTime=Sun Sep 26 21:00:25 CST 2021, time=2021-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964290, encodeId=e8e3964290c7, content=家人们，有provisionallly accepted后12天了还没有消息的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=422f2183692, createdName=1207b533m17(暂无昵称), createdTime=Mon May 10 14:36:14 CST 2021, time=2021-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=899206, encodeId=422f8992066f, content=各位大神，帮忙分析一下，4号投稿，到目前为止还是waiting for potential reviewer assignment，是不是一直还在内审，没有送外审。这么长时间，是不是凶多吉少啊？不然怎么一直也不送外审呢？ Stage Start Date Waiting for Potential Reviewer Assignment 6th Nov 20 Monitoring Editor Assigned 6th Nov 20 Potential Monitoring Editor Assigned 6th Nov 20 Under Consideration 6th Nov 20 Editor Assigned 4th Nov 20 Author Approved Converted Files 4th Nov 20 Submission 4th Nov 20 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=34, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83er7omvCdrmoiau28QcV3H4RuWMlgEn4ERibKwHNCMmj9K8hUpRAoicen2hBaia35S1oUmMibEibUPfCnTGQ/132, createdBy=61641658368, createdName=jeffrey1000, createdTime=Sat Nov 14 22:25:19 CST 2020, time=2020-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1000541, encodeId=f75110005414f, content=6月25号，所有审稿人分配，目前毫无消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0e651997208, createdName=zyg1, createdTime=Sun Jul 18 10:36:51 CST 2021, time=2021-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999607, encodeId=b56c99960ec0, content=去年通讯了一篇，感觉比较严谨，抓细节。改了两个月，接收。新颖性和意义要求比不上cancer res，但总体差距不大。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4fed1686029, createdName=cindichaw, createdTime=Thu Jul 15 00:02:30 CST 2021, time=2021-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997716, encodeId=db4499e7165c, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1625453153, createdName=代攻悯, createdTime=Thu Jul 08 23:01:36 CST 2021, time=2021-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=963411, encodeId=d874963411bd, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：Cancer 经验分享：Waiting for Potential Reviewer Assignment 6th May 21 Monitoring Editor Assigned 6th May 21 Potential Monitoring Editor Assigned 6th May 21 Under Consideration 6th May 21 Editor Assigned 5th May 21 Author Approved Converted Files 5th May 21 Submission 5th May 21 前天投了一篇Review，请教各位大神, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1917110347, createdName=ruiruima, createdTime=Fri May 07 15:08:09 CST 2021, time=2021-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=960576, encodeId=8eca9605e626, content=偏重的研究方向：肿瘤 经验分享：我的All Reviewers Assigned已经41天了，好着急~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a2981665569, createdName=1ddfbe67m31(暂无匿称), createdTime=Mon Apr 26 11:10:41 CST 2021, time=2021-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967695, encodeId=57f396e6956f, content=今年不知道能不能过10, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eq21jfT3FiamV2B5gV9Jk3usBEjxr1eRPovMP5G0pnvlyt5337ZpsncLiaxscoeURoMFIkxUJSRGicIQ/132, createdBy=c1c01623244, createdName=956656866, createdTime=Sat May 22 12:05:51 CST 2021, time=2021-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587003, encodeId=7c5058e00351, content=同问大佬，这个期刊审稿周期如何simply_yang_40770823 2020-03-09 00:00:00 发表: 我刚交，按页数，我的是1898镑，17000多, beContent=simply_yang_40770823 2020-03-09 00:00:00 发表: 我刚交，按页数，我的是1898镑，17000多, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIicOgVWqMW8xlo254fWMSATzTog5MrnYxbl0ibdUUzAgLhaWxmG5LxhPnSbECxAhOpV1uibMibrBvD9w/132, createdBy=c5c02177380, createdName=tdavid, createdTime=Fri Mar 20 00:00:00 CST 2020, time=2020-03-20, status=1, ipAttribution=)]

2021-09-26 ms3000001738384174

感觉虽然有近10分，但投了一篇感觉蛮简单的，做蛋白对肿瘤作用的小伙伴可以大胆尝试一下。
审了两轮，也可能是运气比较好，审稿人问的问题都不难。
估计期刊整体对国人也比较友好。

77 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=1055113, encodeId=75d71055113f0, content=感觉虽然有近10分，但投了一篇感觉蛮简单的，做蛋白对肿瘤作用的小伙伴可以大胆尝试一下。 审了两轮，也可能是运气比较好，审稿人问的问题都不难。 估计期刊整体对国人也比较友好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=23305505580, createdName=ms3000001738384174, createdTime=Sun Sep 26 21:00:25 CST 2021, time=2021-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964290, encodeId=e8e3964290c7, content=家人们，有provisionallly accepted后12天了还没有消息的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=422f2183692, createdName=1207b533m17(暂无昵称), createdTime=Mon May 10 14:36:14 CST 2021, time=2021-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=899206, encodeId=422f8992066f, content=各位大神，帮忙分析一下，4号投稿，到目前为止还是waiting for potential reviewer assignment，是不是一直还在内审，没有送外审。这么长时间，是不是凶多吉少啊？不然怎么一直也不送外审呢？ Stage Start Date Waiting for Potential Reviewer Assignment 6th Nov 20 Monitoring Editor Assigned 6th Nov 20 Potential Monitoring Editor Assigned 6th Nov 20 Under Consideration 6th Nov 20 Editor Assigned 4th Nov 20 Author Approved Converted Files 4th Nov 20 Submission 4th Nov 20 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=34, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83er7omvCdrmoiau28QcV3H4RuWMlgEn4ERibKwHNCMmj9K8hUpRAoicen2hBaia35S1oUmMibEibUPfCnTGQ/132, createdBy=61641658368, createdName=jeffrey1000, createdTime=Sat Nov 14 22:25:19 CST 2020, time=2020-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1000541, encodeId=f75110005414f, content=6月25号，所有审稿人分配，目前毫无消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0e651997208, createdName=zyg1, createdTime=Sun Jul 18 10:36:51 CST 2021, time=2021-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999607, encodeId=b56c99960ec0, content=去年通讯了一篇，感觉比较严谨，抓细节。改了两个月，接收。新颖性和意义要求比不上cancer res，但总体差距不大。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4fed1686029, createdName=cindichaw, createdTime=Thu Jul 15 00:02:30 CST 2021, time=2021-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997716, encodeId=db4499e7165c, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1625453153, createdName=代攻悯, createdTime=Thu Jul 08 23:01:36 CST 2021, time=2021-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=963411, encodeId=d874963411bd, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：Cancer 经验分享：Waiting for Potential Reviewer Assignment 6th May 21 Monitoring Editor Assigned 6th May 21 Potential Monitoring Editor Assigned 6th May 21 Under Consideration 6th May 21 Editor Assigned 5th May 21 Author Approved Converted Files 5th May 21 Submission 5th May 21 前天投了一篇Review，请教各位大神, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1917110347, createdName=ruiruima, createdTime=Fri May 07 15:08:09 CST 2021, time=2021-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=960576, encodeId=8eca9605e626, content=偏重的研究方向：肿瘤 经验分享：我的All Reviewers Assigned已经41天了，好着急~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a2981665569, createdName=1ddfbe67m31(暂无匿称), createdTime=Mon Apr 26 11:10:41 CST 2021, time=2021-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967695, encodeId=57f396e6956f, content=今年不知道能不能过10, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eq21jfT3FiamV2B5gV9Jk3usBEjxr1eRPovMP5G0pnvlyt5337ZpsncLiaxscoeURoMFIkxUJSRGicIQ/132, createdBy=c1c01623244, createdName=956656866, createdTime=Sat May 22 12:05:51 CST 2021, time=2021-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587003, encodeId=7c5058e00351, content=同问大佬，这个期刊审稿周期如何simply_yang_40770823 2020-03-09 00:00:00 发表: 我刚交，按页数，我的是1898镑，17000多, beContent=simply_yang_40770823 2020-03-09 00:00:00 发表: 我刚交，按页数，我的是1898镑，17000多, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIicOgVWqMW8xlo254fWMSATzTog5MrnYxbl0ibdUUzAgLhaWxmG5LxhPnSbECxAhOpV1uibMibrBvD9w/132, createdBy=c5c02177380, createdName=tdavid, createdTime=Fri Mar 20 00:00:00 CST 2020, time=2020-03-20, status=1, ipAttribution=)]

2021-05-10 1207b533m17(暂无昵称)

家人们，有provisionallly accepted后12天了还没有消息的吗

46 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1055113, encodeId=75d71055113f0, content=感觉虽然有近10分，但投了一篇感觉蛮简单的，做蛋白对肿瘤作用的小伙伴可以大胆尝试一下。 审了两轮，也可能是运气比较好，审稿人问的问题都不难。 估计期刊整体对国人也比较友好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=23305505580, createdName=ms3000001738384174, createdTime=Sun Sep 26 21:00:25 CST 2021, time=2021-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964290, encodeId=e8e3964290c7, content=家人们，有provisionallly accepted后12天了还没有消息的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=422f2183692, createdName=1207b533m17(暂无昵称), createdTime=Mon May 10 14:36:14 CST 2021, time=2021-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=899206, encodeId=422f8992066f, content=各位大神，帮忙分析一下，4号投稿，到目前为止还是waiting for potential reviewer assignment，是不是一直还在内审，没有送外审。这么长时间，是不是凶多吉少啊？不然怎么一直也不送外审呢？ Stage Start Date Waiting for Potential Reviewer Assignment 6th Nov 20 Monitoring Editor Assigned 6th Nov 20 Potential Monitoring Editor Assigned 6th Nov 20 Under Consideration 6th Nov 20 Editor Assigned 4th Nov 20 Author Approved Converted Files 4th Nov 20 Submission 4th Nov 20 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=34, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83er7omvCdrmoiau28QcV3H4RuWMlgEn4ERibKwHNCMmj9K8hUpRAoicen2hBaia35S1oUmMibEibUPfCnTGQ/132, createdBy=61641658368, createdName=jeffrey1000, createdTime=Sat Nov 14 22:25:19 CST 2020, time=2020-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1000541, encodeId=f75110005414f, content=6月25号，所有审稿人分配，目前毫无消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0e651997208, createdName=zyg1, createdTime=Sun Jul 18 10:36:51 CST 2021, time=2021-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999607, encodeId=b56c99960ec0, content=去年通讯了一篇，感觉比较严谨，抓细节。改了两个月，接收。新颖性和意义要求比不上cancer res，但总体差距不大。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4fed1686029, createdName=cindichaw, createdTime=Thu Jul 15 00:02:30 CST 2021, time=2021-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997716, encodeId=db4499e7165c, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1625453153, createdName=代攻悯, createdTime=Thu Jul 08 23:01:36 CST 2021, time=2021-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=963411, encodeId=d874963411bd, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：Cancer 经验分享：Waiting for Potential Reviewer Assignment 6th May 21 Monitoring Editor Assigned 6th May 21 Potential Monitoring Editor Assigned 6th May 21 Under Consideration 6th May 21 Editor Assigned 5th May 21 Author Approved Converted Files 5th May 21 Submission 5th May 21 前天投了一篇Review，请教各位大神, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1917110347, createdName=ruiruima, createdTime=Fri May 07 15:08:09 CST 2021, time=2021-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=960576, encodeId=8eca9605e626, content=偏重的研究方向：肿瘤 经验分享：我的All Reviewers Assigned已经41天了，好着急~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a2981665569, createdName=1ddfbe67m31(暂无匿称), createdTime=Mon Apr 26 11:10:41 CST 2021, time=2021-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967695, encodeId=57f396e6956f, content=今年不知道能不能过10, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eq21jfT3FiamV2B5gV9Jk3usBEjxr1eRPovMP5G0pnvlyt5337ZpsncLiaxscoeURoMFIkxUJSRGicIQ/132, createdBy=c1c01623244, createdName=956656866, createdTime=Sat May 22 12:05:51 CST 2021, time=2021-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587003, encodeId=7c5058e00351, content=同问大佬，这个期刊审稿周期如何simply_yang_40770823 2020-03-09 00:00:00 发表: 我刚交，按页数，我的是1898镑，17000多, beContent=simply_yang_40770823 2020-03-09 00:00:00 发表: 我刚交，按页数，我的是1898镑，17000多, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIicOgVWqMW8xlo254fWMSATzTog5MrnYxbl0ibdUUzAgLhaWxmG5LxhPnSbECxAhOpV1uibMibrBvD9w/132, createdBy=c5c02177380, createdName=tdavid, createdTime=Fri Mar 20 00:00:00 CST 2020, time=2020-03-20, status=1, ipAttribution=)]

2020-11-14 jeffrey1000

各位大神，帮忙分析一下，4号投稿，到目前为止还是waiting for potential reviewer assignment，是不是一直还在内审，没有送外审。这么长时间，是不是凶多吉少啊？不然怎么一直也不送外审呢？ Stage Start Date Waiting for Potential Reviewer Assignment 6th Nov 20 Monitoring Editor Assigned 6th Nov 20 Potential Monitoring Editor Assigned 6th Nov 20 Under Consideration 6th Nov 20 Editor Assigned 4th Nov 20 Author Approved Converted Files 4th Nov 20 Submission 4th Nov 20

139 34

展开34条回复

[GetPortalCommentsPageByObjectIdResponse(id=1055113, encodeId=75d71055113f0, content=感觉虽然有近10分，但投了一篇感觉蛮简单的，做蛋白对肿瘤作用的小伙伴可以大胆尝试一下。 审了两轮，也可能是运气比较好，审稿人问的问题都不难。 估计期刊整体对国人也比较友好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=23305505580, createdName=ms3000001738384174, createdTime=Sun Sep 26 21:00:25 CST 2021, time=2021-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964290, encodeId=e8e3964290c7, content=家人们，有provisionallly accepted后12天了还没有消息的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=422f2183692, createdName=1207b533m17(暂无昵称), createdTime=Mon May 10 14:36:14 CST 2021, time=2021-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=899206, encodeId=422f8992066f, content=各位大神，帮忙分析一下，4号投稿，到目前为止还是waiting for potential reviewer assignment，是不是一直还在内审，没有送外审。这么长时间，是不是凶多吉少啊？不然怎么一直也不送外审呢？ Stage Start Date Waiting for Potential Reviewer Assignment 6th Nov 20 Monitoring Editor Assigned 6th Nov 20 Potential Monitoring Editor Assigned 6th Nov 20 Under Consideration 6th Nov 20 Editor Assigned 4th Nov 20 Author Approved Converted Files 4th Nov 20 Submission 4th Nov 20 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=34, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83er7omvCdrmoiau28QcV3H4RuWMlgEn4ERibKwHNCMmj9K8hUpRAoicen2hBaia35S1oUmMibEibUPfCnTGQ/132, createdBy=61641658368, createdName=jeffrey1000, createdTime=Sat Nov 14 22:25:19 CST 2020, time=2020-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1000541, encodeId=f75110005414f, content=6月25号，所有审稿人分配，目前毫无消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0e651997208, createdName=zyg1, createdTime=Sun Jul 18 10:36:51 CST 2021, time=2021-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999607, encodeId=b56c99960ec0, content=去年通讯了一篇，感觉比较严谨，抓细节。改了两个月，接收。新颖性和意义要求比不上cancer res，但总体差距不大。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4fed1686029, createdName=cindichaw, createdTime=Thu Jul 15 00:02:30 CST 2021, time=2021-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997716, encodeId=db4499e7165c, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1625453153, createdName=代攻悯, createdTime=Thu Jul 08 23:01:36 CST 2021, time=2021-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=963411, encodeId=d874963411bd, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：Cancer 经验分享：Waiting for Potential Reviewer Assignment 6th May 21 Monitoring Editor Assigned 6th May 21 Potential Monitoring Editor Assigned 6th May 21 Under Consideration 6th May 21 Editor Assigned 5th May 21 Author Approved Converted Files 5th May 21 Submission 5th May 21 前天投了一篇Review，请教各位大神, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1917110347, createdName=ruiruima, createdTime=Fri May 07 15:08:09 CST 2021, time=2021-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=960576, encodeId=8eca9605e626, content=偏重的研究方向：肿瘤 经验分享：我的All Reviewers Assigned已经41天了，好着急~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a2981665569, createdName=1ddfbe67m31(暂无匿称), createdTime=Mon Apr 26 11:10:41 CST 2021, time=2021-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967695, encodeId=57f396e6956f, content=今年不知道能不能过10, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eq21jfT3FiamV2B5gV9Jk3usBEjxr1eRPovMP5G0pnvlyt5337ZpsncLiaxscoeURoMFIkxUJSRGicIQ/132, createdBy=c1c01623244, createdName=956656866, createdTime=Sat May 22 12:05:51 CST 2021, time=2021-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587003, encodeId=7c5058e00351, content=同问大佬，这个期刊审稿周期如何simply_yang_40770823 2020-03-09 00:00:00 发表: 我刚交，按页数，我的是1898镑，17000多, beContent=simply_yang_40770823 2020-03-09 00:00:00 发表: 我刚交，按页数，我的是1898镑，17000多, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIicOgVWqMW8xlo254fWMSATzTog5MrnYxbl0ibdUUzAgLhaWxmG5LxhPnSbECxAhOpV1uibMibrBvD9w/132, createdBy=c5c02177380, createdName=tdavid, createdTime=Fri Mar 20 00:00:00 CST 2020, time=2020-03-20, status=1, ipAttribution=)]

2021-07-18 zyg1

6月25号，所有审稿人分配，目前毫无消息

47 0

[GetPortalCommentsPageByObjectIdResponse(id=1055113, encodeId=75d71055113f0, content=感觉虽然有近10分，但投了一篇感觉蛮简单的，做蛋白对肿瘤作用的小伙伴可以大胆尝试一下。 审了两轮，也可能是运气比较好，审稿人问的问题都不难。 估计期刊整体对国人也比较友好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=23305505580, createdName=ms3000001738384174, createdTime=Sun Sep 26 21:00:25 CST 2021, time=2021-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964290, encodeId=e8e3964290c7, content=家人们，有provisionallly accepted后12天了还没有消息的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=422f2183692, createdName=1207b533m17(暂无昵称), createdTime=Mon May 10 14:36:14 CST 2021, time=2021-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=899206, encodeId=422f8992066f, content=各位大神，帮忙分析一下，4号投稿，到目前为止还是waiting for potential reviewer assignment，是不是一直还在内审，没有送外审。这么长时间，是不是凶多吉少啊？不然怎么一直也不送外审呢？ Stage Start Date Waiting for Potential Reviewer Assignment 6th Nov 20 Monitoring Editor Assigned 6th Nov 20 Potential Monitoring Editor Assigned 6th Nov 20 Under Consideration 6th Nov 20 Editor Assigned 4th Nov 20 Author Approved Converted Files 4th Nov 20 Submission 4th Nov 20 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=34, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83er7omvCdrmoiau28QcV3H4RuWMlgEn4ERibKwHNCMmj9K8hUpRAoicen2hBaia35S1oUmMibEibUPfCnTGQ/132, createdBy=61641658368, createdName=jeffrey1000, createdTime=Sat Nov 14 22:25:19 CST 2020, time=2020-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1000541, encodeId=f75110005414f, content=6月25号，所有审稿人分配，目前毫无消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0e651997208, createdName=zyg1, createdTime=Sun Jul 18 10:36:51 CST 2021, time=2021-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999607, encodeId=b56c99960ec0, content=去年通讯了一篇，感觉比较严谨，抓细节。改了两个月，接收。新颖性和意义要求比不上cancer res，但总体差距不大。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4fed1686029, createdName=cindichaw, createdTime=Thu Jul 15 00:02:30 CST 2021, time=2021-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997716, encodeId=db4499e7165c, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1625453153, createdName=代攻悯, createdTime=Thu Jul 08 23:01:36 CST 2021, time=2021-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=963411, encodeId=d874963411bd, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：Cancer 经验分享：Waiting for Potential Reviewer Assignment 6th May 21 Monitoring Editor Assigned 6th May 21 Potential Monitoring Editor Assigned 6th May 21 Under Consideration 6th May 21 Editor Assigned 5th May 21 Author Approved Converted Files 5th May 21 Submission 5th May 21 前天投了一篇Review，请教各位大神, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1917110347, createdName=ruiruima, createdTime=Fri May 07 15:08:09 CST 2021, time=2021-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=960576, encodeId=8eca9605e626, content=偏重的研究方向：肿瘤 经验分享：我的All Reviewers Assigned已经41天了，好着急~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a2981665569, createdName=1ddfbe67m31(暂无匿称), createdTime=Mon Apr 26 11:10:41 CST 2021, time=2021-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967695, encodeId=57f396e6956f, content=今年不知道能不能过10, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eq21jfT3FiamV2B5gV9Jk3usBEjxr1eRPovMP5G0pnvlyt5337ZpsncLiaxscoeURoMFIkxUJSRGicIQ/132, createdBy=c1c01623244, createdName=956656866, createdTime=Sat May 22 12:05:51 CST 2021, time=2021-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587003, encodeId=7c5058e00351, content=同问大佬，这个期刊审稿周期如何simply_yang_40770823 2020-03-09 00:00:00 发表: 我刚交，按页数，我的是1898镑，17000多, beContent=simply_yang_40770823 2020-03-09 00:00:00 发表: 我刚交，按页数，我的是1898镑，17000多, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIicOgVWqMW8xlo254fWMSATzTog5MrnYxbl0ibdUUzAgLhaWxmG5LxhPnSbECxAhOpV1uibMibrBvD9w/132, createdBy=c5c02177380, createdName=tdavid, createdTime=Fri Mar 20 00:00:00 CST 2020, time=2020-03-20, status=1, ipAttribution=)]

2021-07-15 cindichaw

去年通讯了一篇，感觉比较严谨，抓细节。改了两个月，接收。新颖性和意义要求比不上cancer res，但总体差距不大。

54 0

[GetPortalCommentsPageByObjectIdResponse(id=1055113, encodeId=75d71055113f0, content=感觉虽然有近10分，但投了一篇感觉蛮简单的，做蛋白对肿瘤作用的小伙伴可以大胆尝试一下。 审了两轮，也可能是运气比较好，审稿人问的问题都不难。 估计期刊整体对国人也比较友好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=23305505580, createdName=ms3000001738384174, createdTime=Sun Sep 26 21:00:25 CST 2021, time=2021-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964290, encodeId=e8e3964290c7, content=家人们，有provisionallly accepted后12天了还没有消息的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=422f2183692, createdName=1207b533m17(暂无昵称), createdTime=Mon May 10 14:36:14 CST 2021, time=2021-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=899206, encodeId=422f8992066f, content=各位大神，帮忙分析一下，4号投稿，到目前为止还是waiting for potential reviewer assignment，是不是一直还在内审，没有送外审。这么长时间，是不是凶多吉少啊？不然怎么一直也不送外审呢？ Stage Start Date Waiting for Potential Reviewer Assignment 6th Nov 20 Monitoring Editor Assigned 6th Nov 20 Potential Monitoring Editor Assigned 6th Nov 20 Under Consideration 6th Nov 20 Editor Assigned 4th Nov 20 Author Approved Converted Files 4th Nov 20 Submission 4th Nov 20 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=34, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83er7omvCdrmoiau28QcV3H4RuWMlgEn4ERibKwHNCMmj9K8hUpRAoicen2hBaia35S1oUmMibEibUPfCnTGQ/132, createdBy=61641658368, createdName=jeffrey1000, createdTime=Sat Nov 14 22:25:19 CST 2020, time=2020-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1000541, encodeId=f75110005414f, content=6月25号，所有审稿人分配，目前毫无消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0e651997208, createdName=zyg1, createdTime=Sun Jul 18 10:36:51 CST 2021, time=2021-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999607, encodeId=b56c99960ec0, content=去年通讯了一篇，感觉比较严谨，抓细节。改了两个月，接收。新颖性和意义要求比不上cancer res，但总体差距不大。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4fed1686029, createdName=cindichaw, createdTime=Thu Jul 15 00:02:30 CST 2021, time=2021-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997716, encodeId=db4499e7165c, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1625453153, createdName=代攻悯, createdTime=Thu Jul 08 23:01:36 CST 2021, time=2021-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=963411, encodeId=d874963411bd, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：Cancer 经验分享：Waiting for Potential Reviewer Assignment 6th May 21 Monitoring Editor Assigned 6th May 21 Potential Monitoring Editor Assigned 6th May 21 Under Consideration 6th May 21 Editor Assigned 5th May 21 Author Approved Converted Files 5th May 21 Submission 5th May 21 前天投了一篇Review，请教各位大神, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1917110347, createdName=ruiruima, createdTime=Fri May 07 15:08:09 CST 2021, time=2021-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=960576, encodeId=8eca9605e626, content=偏重的研究方向：肿瘤 经验分享：我的All Reviewers Assigned已经41天了，好着急~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a2981665569, createdName=1ddfbe67m31(暂无匿称), createdTime=Mon Apr 26 11:10:41 CST 2021, time=2021-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967695, encodeId=57f396e6956f, content=今年不知道能不能过10, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eq21jfT3FiamV2B5gV9Jk3usBEjxr1eRPovMP5G0pnvlyt5337ZpsncLiaxscoeURoMFIkxUJSRGicIQ/132, createdBy=c1c01623244, createdName=956656866, createdTime=Sat May 22 12:05:51 CST 2021, time=2021-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587003, encodeId=7c5058e00351, content=同问大佬，这个期刊审稿周期如何simply_yang_40770823 2020-03-09 00:00:00 发表: 我刚交，按页数，我的是1898镑，17000多, beContent=simply_yang_40770823 2020-03-09 00:00:00 发表: 我刚交，按页数，我的是1898镑，17000多, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIicOgVWqMW8xlo254fWMSATzTog5MrnYxbl0ibdUUzAgLhaWxmG5LxhPnSbECxAhOpV1uibMibrBvD9w/132, createdBy=c5c02177380, createdName=tdavid, createdTime=Fri Mar 20 00:00:00 CST 2020, time=2020-03-20, status=1, ipAttribution=)]

2021-07-08 代攻悯

无

41 0

[GetPortalCommentsPageByObjectIdResponse(id=1055113, encodeId=75d71055113f0, content=感觉虽然有近10分，但投了一篇感觉蛮简单的，做蛋白对肿瘤作用的小伙伴可以大胆尝试一下。 审了两轮，也可能是运气比较好，审稿人问的问题都不难。 估计期刊整体对国人也比较友好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=23305505580, createdName=ms3000001738384174, createdTime=Sun Sep 26 21:00:25 CST 2021, time=2021-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964290, encodeId=e8e3964290c7, content=家人们，有provisionallly accepted后12天了还没有消息的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=422f2183692, createdName=1207b533m17(暂无昵称), createdTime=Mon May 10 14:36:14 CST 2021, time=2021-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=899206, encodeId=422f8992066f, content=各位大神，帮忙分析一下，4号投稿，到目前为止还是waiting for potential reviewer assignment，是不是一直还在内审，没有送外审。这么长时间，是不是凶多吉少啊？不然怎么一直也不送外审呢？ Stage Start Date Waiting for Potential Reviewer Assignment 6th Nov 20 Monitoring Editor Assigned 6th Nov 20 Potential Monitoring Editor Assigned 6th Nov 20 Under Consideration 6th Nov 20 Editor Assigned 4th Nov 20 Author Approved Converted Files 4th Nov 20 Submission 4th Nov 20 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=34, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83er7omvCdrmoiau28QcV3H4RuWMlgEn4ERibKwHNCMmj9K8hUpRAoicen2hBaia35S1oUmMibEibUPfCnTGQ/132, createdBy=61641658368, createdName=jeffrey1000, createdTime=Sat Nov 14 22:25:19 CST 2020, time=2020-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1000541, encodeId=f75110005414f, content=6月25号，所有审稿人分配，目前毫无消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0e651997208, createdName=zyg1, createdTime=Sun Jul 18 10:36:51 CST 2021, time=2021-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999607, encodeId=b56c99960ec0, content=去年通讯了一篇，感觉比较严谨，抓细节。改了两个月，接收。新颖性和意义要求比不上cancer res，但总体差距不大。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4fed1686029, createdName=cindichaw, createdTime=Thu Jul 15 00:02:30 CST 2021, time=2021-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997716, encodeId=db4499e7165c, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1625453153, createdName=代攻悯, createdTime=Thu Jul 08 23:01:36 CST 2021, time=2021-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=963411, encodeId=d874963411bd, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：Cancer 经验分享：Waiting for Potential Reviewer Assignment 6th May 21 Monitoring Editor Assigned 6th May 21 Potential Monitoring Editor Assigned 6th May 21 Under Consideration 6th May 21 Editor Assigned 5th May 21 Author Approved Converted Files 5th May 21 Submission 5th May 21 前天投了一篇Review，请教各位大神, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1917110347, createdName=ruiruima, createdTime=Fri May 07 15:08:09 CST 2021, time=2021-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=960576, encodeId=8eca9605e626, content=偏重的研究方向：肿瘤 经验分享：我的All Reviewers Assigned已经41天了，好着急~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a2981665569, createdName=1ddfbe67m31(暂无匿称), createdTime=Mon Apr 26 11:10:41 CST 2021, time=2021-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967695, encodeId=57f396e6956f, content=今年不知道能不能过10, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eq21jfT3FiamV2B5gV9Jk3usBEjxr1eRPovMP5G0pnvlyt5337ZpsncLiaxscoeURoMFIkxUJSRGicIQ/132, createdBy=c1c01623244, createdName=956656866, createdTime=Sat May 22 12:05:51 CST 2021, time=2021-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587003, encodeId=7c5058e00351, content=同问大佬，这个期刊审稿周期如何simply_yang_40770823 2020-03-09 00:00:00 发表: 我刚交，按页数，我的是1898镑，17000多, beContent=simply_yang_40770823 2020-03-09 00:00:00 发表: 我刚交，按页数，我的是1898镑，17000多, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIicOgVWqMW8xlo254fWMSATzTog5MrnYxbl0ibdUUzAgLhaWxmG5LxhPnSbECxAhOpV1uibMibrBvD9w/132, createdBy=c5c02177380, createdName=tdavid, createdTime=Fri Mar 20 00:00:00 CST 2020, time=2020-03-20, status=1, ipAttribution=)]

2021-05-07 ruiruima

审稿速度:2.0 | 投稿命中率:50.0
偏重的研究方向：Cancer
经验分享：Waiting for Potential Reviewer Assignment 6th May 21
Monitoring Editor Assigned 6th May 21
Potential Monitoring Editor Assigned 6th May 21
Under Consideration 6th May 21
Editor Assigned 5th May 21
Author Approved Converted Files 5th May 21
Submission 5th May 21
前天投了一篇Review，请教各位大神

76 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1055113, encodeId=75d71055113f0, content=感觉虽然有近10分，但投了一篇感觉蛮简单的，做蛋白对肿瘤作用的小伙伴可以大胆尝试一下。 审了两轮，也可能是运气比较好，审稿人问的问题都不难。 估计期刊整体对国人也比较友好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=23305505580, createdName=ms3000001738384174, createdTime=Sun Sep 26 21:00:25 CST 2021, time=2021-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964290, encodeId=e8e3964290c7, content=家人们，有provisionallly accepted后12天了还没有消息的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=422f2183692, createdName=1207b533m17(暂无昵称), createdTime=Mon May 10 14:36:14 CST 2021, time=2021-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=899206, encodeId=422f8992066f, content=各位大神，帮忙分析一下，4号投稿，到目前为止还是waiting for potential reviewer assignment，是不是一直还在内审，没有送外审。这么长时间，是不是凶多吉少啊？不然怎么一直也不送外审呢？ Stage Start Date Waiting for Potential Reviewer Assignment 6th Nov 20 Monitoring Editor Assigned 6th Nov 20 Potential Monitoring Editor Assigned 6th Nov 20 Under Consideration 6th Nov 20 Editor Assigned 4th Nov 20 Author Approved Converted Files 4th Nov 20 Submission 4th Nov 20 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=34, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83er7omvCdrmoiau28QcV3H4RuWMlgEn4ERibKwHNCMmj9K8hUpRAoicen2hBaia35S1oUmMibEibUPfCnTGQ/132, createdBy=61641658368, createdName=jeffrey1000, createdTime=Sat Nov 14 22:25:19 CST 2020, time=2020-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1000541, encodeId=f75110005414f, content=6月25号，所有审稿人分配，目前毫无消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0e651997208, createdName=zyg1, createdTime=Sun Jul 18 10:36:51 CST 2021, time=2021-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999607, encodeId=b56c99960ec0, content=去年通讯了一篇，感觉比较严谨，抓细节。改了两个月，接收。新颖性和意义要求比不上cancer res，但总体差距不大。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4fed1686029, createdName=cindichaw, createdTime=Thu Jul 15 00:02:30 CST 2021, time=2021-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997716, encodeId=db4499e7165c, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1625453153, createdName=代攻悯, createdTime=Thu Jul 08 23:01:36 CST 2021, time=2021-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=963411, encodeId=d874963411bd, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：Cancer 经验分享：Waiting for Potential Reviewer Assignment 6th May 21 Monitoring Editor Assigned 6th May 21 Potential Monitoring Editor Assigned 6th May 21 Under Consideration 6th May 21 Editor Assigned 5th May 21 Author Approved Converted Files 5th May 21 Submission 5th May 21 前天投了一篇Review，请教各位大神, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1917110347, createdName=ruiruima, createdTime=Fri May 07 15:08:09 CST 2021, time=2021-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=960576, encodeId=8eca9605e626, content=偏重的研究方向：肿瘤 经验分享：我的All Reviewers Assigned已经41天了，好着急~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a2981665569, createdName=1ddfbe67m31(暂无匿称), createdTime=Mon Apr 26 11:10:41 CST 2021, time=2021-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967695, encodeId=57f396e6956f, content=今年不知道能不能过10, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eq21jfT3FiamV2B5gV9Jk3usBEjxr1eRPovMP5G0pnvlyt5337ZpsncLiaxscoeURoMFIkxUJSRGicIQ/132, createdBy=c1c01623244, createdName=956656866, createdTime=Sat May 22 12:05:51 CST 2021, time=2021-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587003, encodeId=7c5058e00351, content=同问大佬，这个期刊审稿周期如何simply_yang_40770823 2020-03-09 00:00:00 发表: 我刚交，按页数，我的是1898镑，17000多, beContent=simply_yang_40770823 2020-03-09 00:00:00 发表: 我刚交，按页数，我的是1898镑，17000多, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIicOgVWqMW8xlo254fWMSATzTog5MrnYxbl0ibdUUzAgLhaWxmG5LxhPnSbECxAhOpV1uibMibrBvD9w/132, createdBy=c5c02177380, createdName=tdavid, createdTime=Fri Mar 20 00:00:00 CST 2020, time=2020-03-20, status=1, ipAttribution=)]

2021-04-26 1ddfbe67m31(暂无匿称)

偏重的研究方向：肿瘤
经验分享：我的All Reviewers Assigned已经41天了，好着急~

59 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1055113, encodeId=75d71055113f0, content=感觉虽然有近10分，但投了一篇感觉蛮简单的，做蛋白对肿瘤作用的小伙伴可以大胆尝试一下。 审了两轮，也可能是运气比较好，审稿人问的问题都不难。 估计期刊整体对国人也比较友好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=23305505580, createdName=ms3000001738384174, createdTime=Sun Sep 26 21:00:25 CST 2021, time=2021-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964290, encodeId=e8e3964290c7, content=家人们，有provisionallly accepted后12天了还没有消息的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=422f2183692, createdName=1207b533m17(暂无昵称), createdTime=Mon May 10 14:36:14 CST 2021, time=2021-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=899206, encodeId=422f8992066f, content=各位大神，帮忙分析一下，4号投稿，到目前为止还是waiting for potential reviewer assignment，是不是一直还在内审，没有送外审。这么长时间，是不是凶多吉少啊？不然怎么一直也不送外审呢？ Stage Start Date Waiting for Potential Reviewer Assignment 6th Nov 20 Monitoring Editor Assigned 6th Nov 20 Potential Monitoring Editor Assigned 6th Nov 20 Under Consideration 6th Nov 20 Editor Assigned 4th Nov 20 Author Approved Converted Files 4th Nov 20 Submission 4th Nov 20 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=34, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83er7omvCdrmoiau28QcV3H4RuWMlgEn4ERibKwHNCMmj9K8hUpRAoicen2hBaia35S1oUmMibEibUPfCnTGQ/132, createdBy=61641658368, createdName=jeffrey1000, createdTime=Sat Nov 14 22:25:19 CST 2020, time=2020-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1000541, encodeId=f75110005414f, content=6月25号，所有审稿人分配，目前毫无消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0e651997208, createdName=zyg1, createdTime=Sun Jul 18 10:36:51 CST 2021, time=2021-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999607, encodeId=b56c99960ec0, content=去年通讯了一篇，感觉比较严谨，抓细节。改了两个月，接收。新颖性和意义要求比不上cancer res，但总体差距不大。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4fed1686029, createdName=cindichaw, createdTime=Thu Jul 15 00:02:30 CST 2021, time=2021-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997716, encodeId=db4499e7165c, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1625453153, createdName=代攻悯, createdTime=Thu Jul 08 23:01:36 CST 2021, time=2021-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=963411, encodeId=d874963411bd, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：Cancer 经验分享：Waiting for Potential Reviewer Assignment 6th May 21 Monitoring Editor Assigned 6th May 21 Potential Monitoring Editor Assigned 6th May 21 Under Consideration 6th May 21 Editor Assigned 5th May 21 Author Approved Converted Files 5th May 21 Submission 5th May 21 前天投了一篇Review，请教各位大神, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1917110347, createdName=ruiruima, createdTime=Fri May 07 15:08:09 CST 2021, time=2021-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=960576, encodeId=8eca9605e626, content=偏重的研究方向：肿瘤 经验分享：我的All Reviewers Assigned已经41天了，好着急~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a2981665569, createdName=1ddfbe67m31(暂无匿称), createdTime=Mon Apr 26 11:10:41 CST 2021, time=2021-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967695, encodeId=57f396e6956f, content=今年不知道能不能过10, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eq21jfT3FiamV2B5gV9Jk3usBEjxr1eRPovMP5G0pnvlyt5337ZpsncLiaxscoeURoMFIkxUJSRGicIQ/132, createdBy=c1c01623244, createdName=956656866, createdTime=Sat May 22 12:05:51 CST 2021, time=2021-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587003, encodeId=7c5058e00351, content=同问大佬，这个期刊审稿周期如何simply_yang_40770823 2020-03-09 00:00:00 发表: 我刚交，按页数，我的是1898镑，17000多, beContent=simply_yang_40770823 2020-03-09 00:00:00 发表: 我刚交，按页数，我的是1898镑，17000多, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIicOgVWqMW8xlo254fWMSATzTog5MrnYxbl0ibdUUzAgLhaWxmG5LxhPnSbECxAhOpV1uibMibrBvD9w/132, createdBy=c5c02177380, createdName=tdavid, createdTime=Fri Mar 20 00:00:00 CST 2020, time=2020-03-20, status=1, ipAttribution=)]

2021-05-22 956656866

今年不知道能不能过10

55 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1055113, encodeId=75d71055113f0, content=感觉虽然有近10分，但投了一篇感觉蛮简单的，做蛋白对肿瘤作用的小伙伴可以大胆尝试一下。 审了两轮，也可能是运气比较好，审稿人问的问题都不难。 估计期刊整体对国人也比较友好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=23305505580, createdName=ms3000001738384174, createdTime=Sun Sep 26 21:00:25 CST 2021, time=2021-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964290, encodeId=e8e3964290c7, content=家人们，有provisionallly accepted后12天了还没有消息的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=422f2183692, createdName=1207b533m17(暂无昵称), createdTime=Mon May 10 14:36:14 CST 2021, time=2021-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=899206, encodeId=422f8992066f, content=各位大神，帮忙分析一下，4号投稿，到目前为止还是waiting for potential reviewer assignment，是不是一直还在内审，没有送外审。这么长时间，是不是凶多吉少啊？不然怎么一直也不送外审呢？ Stage Start Date Waiting for Potential Reviewer Assignment 6th Nov 20 Monitoring Editor Assigned 6th Nov 20 Potential Monitoring Editor Assigned 6th Nov 20 Under Consideration 6th Nov 20 Editor Assigned 4th Nov 20 Author Approved Converted Files 4th Nov 20 Submission 4th Nov 20 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=34, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83er7omvCdrmoiau28QcV3H4RuWMlgEn4ERibKwHNCMmj9K8hUpRAoicen2hBaia35S1oUmMibEibUPfCnTGQ/132, createdBy=61641658368, createdName=jeffrey1000, createdTime=Sat Nov 14 22:25:19 CST 2020, time=2020-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1000541, encodeId=f75110005414f, content=6月25号，所有审稿人分配，目前毫无消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0e651997208, createdName=zyg1, createdTime=Sun Jul 18 10:36:51 CST 2021, time=2021-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999607, encodeId=b56c99960ec0, content=去年通讯了一篇，感觉比较严谨，抓细节。改了两个月，接收。新颖性和意义要求比不上cancer res，但总体差距不大。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4fed1686029, createdName=cindichaw, createdTime=Thu Jul 15 00:02:30 CST 2021, time=2021-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997716, encodeId=db4499e7165c, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1625453153, createdName=代攻悯, createdTime=Thu Jul 08 23:01:36 CST 2021, time=2021-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=963411, encodeId=d874963411bd, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：Cancer 经验分享：Waiting for Potential Reviewer Assignment 6th May 21 Monitoring Editor Assigned 6th May 21 Potential Monitoring Editor Assigned 6th May 21 Under Consideration 6th May 21 Editor Assigned 5th May 21 Author Approved Converted Files 5th May 21 Submission 5th May 21 前天投了一篇Review，请教各位大神, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1917110347, createdName=ruiruima, createdTime=Fri May 07 15:08:09 CST 2021, time=2021-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=960576, encodeId=8eca9605e626, content=偏重的研究方向：肿瘤 经验分享：我的All Reviewers Assigned已经41天了，好着急~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a2981665569, createdName=1ddfbe67m31(暂无匿称), createdTime=Mon Apr 26 11:10:41 CST 2021, time=2021-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967695, encodeId=57f396e6956f, content=今年不知道能不能过10, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eq21jfT3FiamV2B5gV9Jk3usBEjxr1eRPovMP5G0pnvlyt5337ZpsncLiaxscoeURoMFIkxUJSRGicIQ/132, createdBy=c1c01623244, createdName=956656866, createdTime=Sat May 22 12:05:51 CST 2021, time=2021-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587003, encodeId=7c5058e00351, content=同问大佬，这个期刊审稿周期如何simply_yang_40770823 2020-03-09 00:00:00 发表: 我刚交，按页数，我的是1898镑，17000多, beContent=simply_yang_40770823 2020-03-09 00:00:00 发表: 我刚交，按页数，我的是1898镑，17000多, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIicOgVWqMW8xlo254fWMSATzTog5MrnYxbl0ibdUUzAgLhaWxmG5LxhPnSbECxAhOpV1uibMibrBvD9w/132, createdBy=c5c02177380, createdName=tdavid, createdTime=Fri Mar 20 00:00:00 CST 2020, time=2020-03-20, status=1, ipAttribution=)]

2020-03-20 tdavid

同问大佬，这个期刊审稿周期如何simply_yang_40770823 2020-03-09 00:00:00 发表:
我刚交，按页数，我的是1898镑，17000多

simply_yang_40770823 2020-03-09 00:00:00 发表: 我刚交，按页数，我的是1898镑，17000多

92 1

展开1条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务